Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors

出版年份 2016 全文链接

标题

作者

关键词

出版物

Volume 23, Issue 9, Pages 2195-2202

出版商

American Association for Cancer Research (AACR)

发表日期

2016-10-26

DOI

10.1158/1078-0432.ccr-16-0966

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now